Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,137
Closed -$4.02M 1835
2026
Q1
$4.02M Buy
53,137
+27,000
+103% +$2.03M 0.02% 593
2025
Q4
$1.95M Sell
26,137
-73,674
-74% -$5.38M 0.01% 845
2025
Q3
$6.74M Buy
+99,811
New +$6.63M 0.05% 390
2025
Q2
Sell
-24,000
Closed -$1.44M 1656
2025
Q1
$1.48M Sell
24,000
-5,000
-17% -$331K 0.01% 788
2024
Q4
$2.09M Buy
+29,000
New +$2.27M 0.02% 675
2022
Q4
Sell
-2,264
Closed -$161K 1462
2022
Q3
$146K Buy
+2,264
New +$157K ﹤0.01% 1286
2020
Q4
Sell
-21,500
Closed -$1.43M 1097
2020
Q3
$1.43M Buy
+21,500
New +$1.36M 0.03% 531
2020
Q1
Sell
-5,000
Closed -$262K 946
2019
Q4
$262K Buy
+5,000
New +$249K 0.01% 703

Other funds holding HOLX

Caption Management's HOLX Position: Q2 2026 in Review

Caption Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 53,137 shares — an estimated $4.02M sold.

Caption Management first reported a position in HOLX in Q4 2019 and held it in 8 quarters. The position peaked at $6.74M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Caption Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Caption Management sold 53,137 Hologic shares in Q2 2026, an estimated $4.02M.
  • Caption Management first reported a position in Hologic in Q4 2019 and held it in 8 quarters.
  • Caption Management's Hologic position peaked at $6.74M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.